<DOC>
	<DOCNO>NCT00372346</DOCNO>
	<brief_summary>Experimental data suggest transplantation endothelial progenitor cell ( EPCs ) attenuate monocrotaline-induced pulmonary hypertension rat dog . In addition , clinical study suggest autogolous progenitor cell transplantation feasible safe patient ischemic disease . This study investigate feasibility , safety , initial clinical outcome intravenous infusion autologous EPCs patient idiopathic pulmonary arterial hypertension .</brief_summary>
	<brief_title>Safety Efficacy Study Transplantation EPCs Treat Idiopathic Pulmonary Arterial Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<criteria>Clinical diagnosis idiopathic pulmonary arterial hypertension 1. New York Heart Association ( NYHA ) functional class II III 2. mean pulmonary artery pressure 30 mmHg right heart catheterization 3. ability walk â‰¥50 standardize 6minute walk test Pulmonary hypertension result heart disease , pulmonary disease , sleepassociated disorder , chronic thromboembolic disease , autoimmune collagen vascular disease , HIV infection , liver disease , NYHA functional class IV , major bleed require blood transfusion , diabetes , renal dysfunction , evidence malignant disease exclude</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2006</verification_date>
</DOC>